Received Sep 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 3J9G4 | — |
administration of an expired dose of Havrix to a patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 47-year-old male patient who received HAV (Havrix) (batch number 3J9G4, expiry date 30-AUG-2025) for prophylaxis. The patient's past medical history included liver transplant. On 08-SEP-2025, the patient received Havrix. On 08-SEP-2025, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: administration of an expired dose of Havrix to a patient). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 11-SEP-2025 The reporter called to inform about the administration of an expired dose of Havrix to a patient, which led to expired vaccine used. According to reporter, the patient received the dose because he was a recent liver transplant recipient.
Medical History/Concurrent Conditions: Liver transplant